Navigation Links
Reimbursement Cuts Will Challenge Japanese Interventional Cardiology Device Market
Date:4/3/2013

TORONTO, April 3, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, prices of interventional cardiology devices in Japan will see significant declines through 2021. The Japanese Ministry of Health, Labor and Welfare (MHLW) is implementing reimbursement cuts every two years in an effort to align Japanese medtech prices with the global market. As a result, most devices, including new products on the market, will see total revenue loss despite increases in use.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO )

The Japanese interventional cardiology device market has seen many recent product launches, particularly stents, and a number of next-generation devices are set to launch over the next ten years. Although bioresorbable vascular scaffolds (BVS) and next-generation drug-eluting stents (DES) are premium devices and will see strong adoption upon entry to the market, the reimbursement cuts will limit prices and impede profits for these products as well.

"The effects of MHLW reimbursement won't be entirely negative," said MRG Analyst Louise Murphy . "Reimbursement coverage by device will encourage physicians to adopt premium devices over standard devices. Despite the biennial cuts, premium devices will maintain higher prices and better reimbursement rates than standard devices, such as bare-metal stents (BMS), and will allow manufacturers to somewhat offset aggregate price declines."

In addition, MHLW coverage of fractional flow reserve (FFR) guidewires was recently expanded to include use in diagnostic procedures, and this offers a huge growth opportunity. Because physicians are reimbursed by device rather than procedure, this expansion has removed barriers to adoption of FFR as a decision-making tool. In fact, the intravascular imaging catheter and pressure guidewire market will be the only segment to expand overall through 2021.

Major competitors in the FFR guidewire space, including Volcano and St. Jude Medical, continue to focus on innovation in an effort to gain market share. This strategy is more difficult for smaller companies, given the high cost of entering the market and the shrinking profit margins in the wake of MHLW reimbursement reform. Therefore, the major players in this market are likely to maintain their lead.

Millennium Research Group's Japanese Markets for Interventional Cardiology Devices 2013 report includes unit, procedure, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, accessory devices, and intravascular imaging catheters and pressure guidewires in Japan.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort

Decision Resources Group

781-993-2597

ccomfort@dresources.com

Alex Jablokow

Millennium Research Group

617-599-8613

ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLOs Seven Nosologies Program
2. Education, Reimbursement Options are Key Components of Effective Pharmaceutical Brand Websites
3. New Study Answers CMS/USPSTF Concerns for CT Colonography Screening Reimbursement: It is a Viable Option for the Medicare-Aged Population
4. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
5. Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive Procedures and Reimbursement for New Indications to Increase Uptake
6. Questcor to Conduct Conference Call to Discuss Reimbursement Process
7. Global Healthcare, Regulatory and Reimbursement Landscape Forecasts and Trends in UAE, Canada and Taiwan
8. Boston Healthcare Expands Health Economics, Pricing, and Reimbursement Consulting Practice in Asia
9. Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures
10. Reimbursement Rates to Have Strong Effect on Adoption of Minimally Invasive Vertebral Compression Fracture Treatments
11. Home Hemodialysis Patients Urge Medicare to Fix HHD Training Reimbursement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:10/2/2017)... The Rebound mobile app is poised to become a vital ... prescription drug addiction. The app empowers users to develop an ... their dosage in a safe, controlled manner while maximizing well-being. ... 100,000 people to sign up will enjoy 3 months of ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):